- Home
- CPT vs ICLR Comparison
CPT vs ICLR Comparison
Compare CPT & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPT | ICLR |
|---|---|---|
| Founded | 1993 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3B | 13.1B |
| IPO Year | 1995 | 2001 |
Fundamental Metrics
Financial Performance| Metric | CPT | ICLR |
|---|---|---|
| Price | $99.93 | $174.88 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 24 | 18 |
| Target Price | $112.83 | ★ $187.76 |
| AVG Volume (30 Days) | ★ 954.9K | 849.3K |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | ★ 4.33% | N/A |
| EPS Growth | ★ 136.00 | N/A |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $12,967,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.91 | $3.63 |
| P/E Ratio | $166.05 | ★ $12.91 |
| Revenue Growth | ★ 81.69 | N/A |
| 52 Week Low | $95.30 | $66.57 |
| 52 Week High | $119.81 | $203.91 |
Technical Indicators
Market Signals| Indicator | CPT | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 43.42 | 50.51 |
| Support Level | $95.92 | $157.92 |
| Resistance Level | $106.13 | $180.90 |
| Average True Range (ATR) | 1.52 | 7.42 |
| MACD | 0.51 | 0.45 |
| Stochastic Oscillator | 71.01 | 51.24 |
Price Performance
Historical ComparisonAbout CPT Camden Property Trust
Camden Property Trust is a real estate investment trust engaged in the ownership, management, development, reposition, redevelopment, acquisition, and construction of multifamily apartment communities. It owned interests in, operated, or developing nearly 175 multifamily properties comprised of nearly 59,921 apartment homes across the United States.
About ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.